相关实验视频

Updated: Jun 3, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

通过具有基因组的血蛋白质探索治疗勃起功能障碍的新型药物标

Zeming Qiu^1,2, Long Cheng^1,2, Qinyuan Wang^2,3

¹Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China.

Sexual medicine

|January 10, 2025

概括

这项研究使用了门德尔的随机化来识别与勃起功能障碍 (ED) 有因果关系的7种血蛋白. 这些发现为ED治疗和预防提供了新的治疗目标.

科学领域:

遗传学遗传学是一个
药理学药理学是指药理学的学科.
泌尿器科泌尿器科泌尿器科泌尿器科

背景情况:

勃起功能障碍 (ED) 在当前的治疗和预防策略中存在重大挑战.
确定新的治疗目标对于推进ED管理至关重要.

研究的目的:

进行全基因组门德尔随机化 (MR) 分析,以确定ED的可用药物治疗点.
研究血蛋白对ED的因果作用,并验证潜在的药物标.

主要方法:

进行了全蛋白质MR和基于总结数据的MR (SMR) 分析,以确定血蛋白和ED之间的因果关系.
丰富分析,蛋白质与蛋白质相互作用 (PPI) 网络,药物预测和分子对接被用于目标验证.
系统的MR评估了与确定目标相关的生活方式和疾病因素.

主要成果:

126种基因预测的血蛋白与ED有因果关系.
TMEM9与ED风险增加有关,而MDH1,NQO1,QDPR,ARL4D,TAGLN2和PPP1R14A与风险降低有关.
已识别的目标参与了代谢和氧化还原过程;分子对接证实了药物结合潜力.

结论:

七种血蛋白 (MDH1,NQO1,QDPR,ARL4D,TAGLN2,TMEM9) 被确定与ED有因果关系.
这些蛋白质可以通过生活方式和疾病因素来调节,为预防和治疗提供了见解.
这项研究为ED病因和潜在的治疗点提供了新的见解,有助于药物开发.

关键词:

门德尔的随机化毒品目标是毒品的目标.这是勃起功能障碍.血蛋白质是血中的蛋白质.

更多相关视频

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

Quantitative Analysis of Chromatin Proteomes in Disease

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

相关概念视频

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Internal Receptors

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.